Compare CADL & SPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CADL | SPH |
|---|---|---|
| Founded | 1999 | 1945 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Specialty Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.2B |
| IPO Year | 2021 | 1996 |
| Metric | CADL | SPH |
|---|---|---|
| Price | $11.74 | $17.00 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $19.00 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 178.4K |
| Earning Date | 05-14-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 6.63% |
| EPS Growth | ★ 58.62 | 42.11 |
| EPS | N/A | ★ 2.48 |
| Revenue | $125,000.00 | ★ $1,432,518,000.00 |
| Revenue This Year | N/A | $2.06 |
| Revenue Next Year | N/A | $1.64 |
| P/E Ratio | ★ N/A | $6.83 |
| Revenue Growth | N/A | ★ 7.94 |
| 52 Week Low | $4.35 | $16.53 |
| 52 Week High | $14.00 | $20.80 |
| Indicator | CADL | SPH |
|---|---|---|
| Relative Strength Index (RSI) | 48.82 | 37.08 |
| Support Level | $9.40 | $16.53 |
| Resistance Level | $14.00 | $17.86 |
| Average True Range (ATR) | 0.71 | 0.24 |
| MACD | -0.18 | -0.02 |
| Stochastic Oscillator | 46.56 | 26.30 |
Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
Suburban Propane Partners LP distributes propane, renewable propane, renewable natural gas (RNG), fuel oil, refined fuels, and markets natural gas and electricity in deregulated markets. It produces and invests in low-carbon fuel alternatives. The company installs and services home comfort heating and ventilation equipment and distributes fuel oil, kerosene, diesel, and gasoline to about 25,000 residential and commercial customers mainly in the U.S. northeast. It operates three segments: Propane, Fuel Oil and Refined Fuels, and Natural Gas and Electricity, with the Propane segment generating the majority of revenue. Propane, a by-product of natural gas processing and petroleum refining, is a clean-burning energy source known for transportability and ease of use.